We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $71.3B
1-Year Est. Return 56.8%
This Fund
S&P 500
This Quarter Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
Cap. Flow
-$2.43B
Cap. Flow %
-3.41%
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128

Top Buys

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$353M
2
MRVL icon
Marvell Technology
MRVL
+$150M
3
SYRE icon
Spyre Therapeutics
SYRE
+$126M
4
BBIO icon
BridgeBio Pharma
BBIO
+$116M
5
DOV icon
Dover
DOV
+$110M

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$713M
2
CNTA
Centessa Pharmaceuticals
CNTA
+$355M
3
CTRA
Coterra Energy
CTRA
+$289M
4
RPRX icon
Royalty Pharma
RPRX
+$259M
5
LLY icon
Eli Lilly
LLY
+$236M

Sector Composition

Rank Sector Weight
1 Technology 32.29%
2 Healthcare 14.03%
3 Financials 12.39%
4 Industrials 8.94%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHAK icon
1076
Shake Shack
SHAK
$2.55B
– –
-230,000
Closed -$20.3M
SHEL icon
1077
Shell
SHEL
$273B
– –
-480,000
Closed -$44.6M
SIMO icon
1078
Silicon Motion
SIMO
$9.42B
– –
-54,687
Closed -$6.14M
SIRI icon
1079
SiriusXM
SIRI
$9.62B
– –
-106,402
Closed -$2.46M
SLVM icon
1080
Sylvamo
SLVM
$1.41B
– –
-270,000
Closed -$11.4M
SO icon
1081
Southern Company
SO
$102B
– –
-1,186,900
Closed -$115M
SSD icon
1082
Simpson Manufacturing
SSD
$7.24B
– –
-157,500
Closed -$27M
SSRM icon
1083
SSR Mining
SSRM
$7.67B
– –
-450,000
Closed -$13.2M
STRO icon
1084
Sutro Biopharma
STRO
$304M
– –
-200,000
Closed -$4.98M
SYY icon
1085
Sysco
SYY
$39.1B
– –
-154,024
Closed -$11M
TERN
1086
DELISTED
Terns Pharmaceuticals
TERN
– –
-2,124,817
Closed -$112M
THG icon
1087
Hanover Insurance
THG
$7.8B
– –
-215,370
Closed -$37.3M
TKR icon
1088
Timken Company
TKR
$8.25B
– –
-168,169
Closed -$16.9M
TRIP icon
1089
TripAdvisor
TRIP
$1.03B
– –
-300,000
Closed -$3.2M
TROW icon
1090
T. Rowe Price
TROW
$23B
– –
-29,201
Closed -$2.63M
UHS icon
1091
Universal Health Services
UHS
$10.4B
– –
-21,153
Closed -$3.79M
UMBF icon
1092
UMB Financial
UMBF
$10.7B
– –
-160,691
Closed -$18.1M
UNH icon
1093
PUT
UnitedHealth
UNH
$353B
– –
-120,000
Closed -$32.5M
VOYA icon
1094
Voya Financial
VOYA
$9.25B
– –
-1,500,000
Closed -$102M
VRDN icon
1095
Viridian Therapeutics
VRDN
$2.58B
– –
-970,018
Closed -$19M
VRE
1096
DELISTED
Veris Residential
VRE
– –
-15,701
Closed -$296K
WH icon
1097
Wyndham Hotels & Resorts
WH
$5.18B
– –
-30,000
Closed -$2.44M
WSC icon
1098
WillScot Mobile Mini Holdings
WSC
$3.51B
– –
-998,888
Closed -$17.3M
WVE icon
1099
Wave Life Sciences
WVE
$948M
– –
-1,000,000
Closed -$7.25M
MRX
1100
Marex Group Limited Ordinary Shares
MRX
$5.45B
– –
-48,107
Closed -$2.14M
42 43
44
45 46

Similar funds

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $72.2B AUM 27.85% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $70.2B AUM 30.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Adage Capital Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.

  • Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
  • Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
  • Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
  • Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
  • Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
  • Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
  • Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.